לברסט

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

LETROZOLE 2.5 MG

Disponibil de la:

RAFA LABORATORIES LTD

Codul ATC:

L02BG04

Forma farmaceutică:

FILM COATED TABLETS

Calea de administrare:

PER OS

Produs de:

SIEGFRIED GENERICS ( MALTA) LTD

Grupul Terapeutică:

LETROZOLE

Indicații terapeutice:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Data de autorizare:

2012-04-01